Response Biomedical Corporation
Records under this name other than the patents Response Biomedical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 7 of 7 · Back to Response Biomedical Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,175,992 | Sensitive immunochromatographic assay Term ended Term ended Apr 28, 2024 · From the USPTO record | Term ended | Term ended Apr 28, 2024 | From the USPTO record |
| US D612,503 | Controller Housing Term ended Term ended Mar 23, 2024 · High confidence | Term ended | Term ended Mar 23, 2024 | High confidence |
| US D612,514 | Reader housing Term ended Term ended Mar 23, 2024 · From the USPTO record | Term ended | Term ended Mar 23, 2024 | From the USPTO record |
| US 7,691,595 | Sensitive immunochromatographic assay Term ended Term ended Aug 30, 2023 · From the USPTO record | Term ended | Term ended Aug 30, 2023 | From the USPTO record |
| US 6,509,196 | Compensation for non-specific signals in quantitative immunoassays Term ended Term ended Jan 4, 2020 · From the USPTO record | Term ended | Term ended Jan 4, 2020 | From the USPTO record |
| US 7,056,473 | Method and apparatus of quantitative assays Lapsed on the fee record Ended Jun 6, 2014 · From the USPTO record | Lapsed on the fee record | Ended Jun 6, 2014 | From the USPTO record |
| US 6,046,019 | Diagnostic kits and methods for making granulocyte cell counts Lapsed on the fee record Ended Apr 4, 2004 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2004 | From the USPTO record |